Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition
Dai Yamanouchi(University of Wisconsin–Madison), Kimihiro Komori(Saiseikai Yahata General Hospital), Hiromine Fujita(Nagoya University), Masanori Nakayama(Max Planck Institute for Heart and Lung Research), Masayuki Sugimoto(Nagoya University), Hiroyuki Kuwano(Gunma University), Masayoshi Kobayashi(Fujita Health University), Hiroshi Banno(Fujisawa City Hospital)
Cited by 54
Related Papers
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Analysis of <i>Epidermal Growth Factor Receptor</i> Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib
|Clinical Cancer Research|2006|589
Spatial regulation of VEGF receptor endocytosis in angiogenesis
|Nature Cell Biology|2013|272
Angiogenic Gene Therapy for Experimental Critical Limb Ischemia
|Circulation Research|2002|238